Total Voting Rights

Summary by AI BETAClose X

NatWest Group plc has announced its total voting rights and capital as of July 31, 2026. The company has 7,959,762,256 ordinary shares issued, excluding treasury shares, with a total of 31,839,049,024 voting rights. Additionally, there are 178,743,441 ordinary shares held in treasury, 240,686 11% Cumulative Preference Shares, and 242,454 5.5% Cumulative Preference Shares. The total number of voting rights across all share classes is 31,840,981,584, which shareholders can use to determine notification requirements under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

NatWest Group plc
31 July 2026
 


NatWest Group plc

Total Voting Rights and Capital

In conformity with the Disclosure Guidance and Transparency Rules, NatWest Group plc ("NWG") hereby notifies the following in respect of its issued share capital with voting rights as at

31 July 2026.

 

Share Class and nominal value

Number of Shares issued

Voting rights per share

Total Voting rights

31 July 2026

Ordinary Shares of £1.0769* (excluding ordinary shares held in treasury)

7,959,762,256

 

 

4

31,839,049,024

Ordinary Shares of £1.0769* held in treasury

 

178,743,441

 

4

Voting rights not exercisable

11% Cumulative Preference Shares of £1

 

240,686

 

4

 

962,744

5.5% Cumulative Preference Shares of £1

 

242,454

 

4

 

969,816

 

Total:

 

8,138,988,837

 

             

31,840,981,584            

* Note: the nominal value of Ordinary Shares without rounding is £1.076923,076923077 per share

 

Shareholders may use the above figure of 31,840,981,584 for their calculations to determine whether they are required to notify their interest in, or a change to their interest in, NWG under the FCA's Disclosure Guidance and Transparency Rules.

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90     

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings